Stock comparison
Aurinia Pharmaceuticals
AUPH$2.04BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.11BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
AUPH 16 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
AUPH1wins
6winsSANOFICONR.NS
55D
B78
54D
A89
59D
B83
81B
B77
63C
A91
49D
A86
48D
A85
Side-by-side metrics
| Metric | AUPH | SANOFICONR.NS |
|---|---|---|
| Market cap | $2.04B | $104.11B Winner |
| P/E (TTM) | Winner: 6.8x | 44.2x |
| EV/EBIT | Winner: 19.1x | 31.8x |
| ROIC (TTM) | 18.99% | 59.15% Winner |
| Gross margin | Winner: 89.74% | 68.13% |
| Net margin | Winner: 99.97% | 27.35% |
| Revenue CAGR 5y | Winner: 57.84% | 27.01% |
| EPS CAGR 5y | - | 20.67% |
| Debt / Equity | 0.1x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AUPH leads on
- P/E (TTM)6.8xvs 44.2x+85%
- Net margin99.97%vs 27.35%+73%
- Revenue CAGR 5y57.84%vs 27.01%+53%
- EV/EBIT19.1xvs 31.8x+40%
SANOFICONR.NS leads on
- Market cap$104.11Bvs $2.04B+98%
- ROIC (TTM)59.15%vs 18.99%+68%
- Debt / Equity0.1xvs 0.1x+47%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.